KAUST Innovation Ventures (KIV) provides investments up to Series A stage for seed to early-stage startups to support our vision of developing KAUST-affiliated technology companies that will bring economic and societal impact to Saudi Arabia. Here's how to get funding.
read moreA KAUST-developed COVID-19 RT-PCR test, the Kingdom’s first, is now SFDA-approved. KAUST startup Noor DX launched the service at KAUST Health last week.
read moreThe on-going COVID-19 crisis has impacted every industry. Startups are among the most affected businesses because of their relative fragility compared to well-established companies. The main reasons startups are losing revenue is due to lost opportunities, hesitant investors, distracted consumers...
read moreMartin Ibarra and Michael Margineanu are two KAUST PhD students with a deep interest in the translational opportunities of bioscience research. Working with KAUST Innovation and Economic Development (I&ED), the pair designed KAUST’s first bio-entrepreneurship ideation workshop for a large...
read moreKAUST Innovation & Economic Development hosted a Gamechanger Day to ignite discussion about healthcare and entrepreneurship in Saudi Arabia. Saudi Arabia is on the brink of a major healthcare transformation from a Government-led system to a privatized one. The Saudi...
read more